OpGen Inc (OPGN):企業の財務・戦略的SWOT分析

◆英語タイトル:OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH188486FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

OpGen Inc (OPGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

OpGen Inc (OpGen) is a precision medicine company that harnesses molecular diagnostics and informatics to prevent infectious diseases caused by multi drug resistant organisms (MDROs). OpGen’s develops products that include QuickFISH, and PNA FISH products, Acuitas molecular diagnostic, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc Key Recent Developments

Dec 09,2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01,2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11,2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15,2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05,2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
OpGen Inc – Key Facts
OpGen Inc – Key Employees
OpGen Inc – Key Employee Biographies
OpGen Inc – Major Products and Services
OpGen Inc – History
OpGen Inc – Company Statement
OpGen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
OpGen Inc – Business Description
Product Category: Collaboration Revenue
Overview
Performance
Product Category: Laboratory Services
Overview
Performance
Product Category: Product Sales
Overview
Performance
R&D Overview
OpGen Inc – SWOT Analysis
SWOT Analysis – Overview
OpGen Inc – Strengths
OpGen Inc – Weaknesses
OpGen Inc – Opportunities
OpGen Inc – Threats
OpGen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
OpGen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 09, 2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01, 2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11, 2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15, 2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05, 2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud
Sep 30, 2020: OpGen announces award of German Government grant funding to its subsidiary Curetis and collaborators
Sep 16, 2020: Collaborative research by OpGen Group company ares genetics and Johns Hopkins researchers demonstrates potential of next-generation sequencing for investigation of genetic antimicrobial resistance mechanisms and molecular susceptibility testing
Aug 12, 2020: OpGen reports second quarter 2020 financial results and provides business update
Jul 15, 2020: OpGen provides business update and announces preliminary unaudited revenue and cash position for second quarter 2020
Jul 13, 2020: Menarini Silicon Biosystems partners with OpGen to broaden distribution of CELLSEARCH platform in North America
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
OpGen Inc, Key Facts
OpGen Inc, Key Employees
OpGen Inc, Key Employee Biographies
OpGen Inc, Major Products and Services
OpGen Inc, History
OpGen Inc, Subsidiaries
OpGen Inc, Key Competitors
OpGen Inc, Ratios based on current share price
OpGen Inc, Annual Ratios
OpGen Inc, Annual Ratios (Cont...1)
OpGen Inc, Interim Ratios
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
OpGen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[OpGen Inc (OPGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hanmi Pharmaceuticals Co Ltd (128940):企業の財務・戦略的SWOT分析
    Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Service Corporation International:企業の戦略・SWOT・財務分析
    Service Corporation International - Strategy, SWOT and Corporate Finance Report Summary Service Corporation International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Star Gas Partners L.P.:企業の戦略・SWOT・財務分析
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Central Reinsurance Corporation:企業の戦略・SWOT・財務情報
    Central Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report Summary Central Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Canadian Western Bank Group (CWB):企業の財務・戦略的SWOT分析
    Canadian Western Bank Group (CWB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Neurimmune Holding AG-製薬・医療分野:企業M&A・提携分析
    Summary Neurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a f …
  • Vionx Energy Corp:電力:M&Aディール及び事業提携情報
    Summary Vionx Energy Corp (Vionx Energy), formerly Premium Power Corp, is a diversified company. The company provides traditional vanadium redox flow batteries and patented battery stack that employs various components including tanks of anolyte and catholyte fluids, power cell at the center of the …
  • J. Front Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • STATS UK Ltd:企業の戦略的SWOT分析
    STATS UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Purdue Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma Inc (Purdue Pharma Canada), a subsidiary of Purdue Pharma LP is a research-based pharmaceutical company that offers services such as development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includ …
  • Gulf Holding Company:企業の戦略的SWOT分析
    Gulf Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • AstraZeneca AB-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca AB (AstraZeneca), a subsidiary of AstraZeneca Plc is a healthcare products provider that research and development of medicinal products. The company offers research and produces drug products in heart and cardiovascular, infection, cancer, metabolic diseases, respiratory, stomach …
  • Owens Corning (OC):企業の財務・戦略的SWOT分析
    Owens Corning (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Uni-President China Holdings Ltd
    Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Geistlich Pharma AG:企業の戦略的SWOT分析
    Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Warp Drive Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Warp Drive Bio Inc (Warp Drive) is a natural products provider. The company utilizes the proprietary genomic mining and small molecule assisted receptor targeting platform to develop novel medicines. Its SMART platform offers solutions to the pharmaceutical opportunities. Warp Drive's integr …
  • Russian Standard Bank:企業の戦略・SWOT・財務情報
    Russian Standard Bank - Strategy, SWOT and Corporate Finance Report Summary Russian Standard Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vestas Wind Systems AS (VWS)-エネルギー分野:企業M&A・提携分析
    Summary Vestas Wind Systems A/S (Vestas) is a renewable energy company that designs, manufactures, constructs, installs, and services wind turbines. The company partners with customers to monitor wind energy production and performance of the wind power plant throughout its lifetime. It offers soluti …
  • University of California San Diego:医療機器:M&Aディール及び事業提携情報
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆